Dr. Ingrid Druwe
|
About meDr. Ingrid Druwe received her BS in Chemistry from Northeastern Illinois University in Chicago, Il. She then attended the University of Arizona where she studied the diabetogenic effects of arsenic and earned her doctorate degree in Pharmacology & Toxicology under the guidance of Dr. Richard R. Vaillancourt. She was the recipient of an NIH Ruth R Kirschstein National Research Service Award (NRSA). Her research also earned the University of Arizona College of Pharmacy Caldwell Award. After earning her doctorate degree Dr. Druwe joined Dr. Bill Mundy’s group at the US EPA National Health Effects and Exposure Laboratory as postdoctoral fellow through a cooperative agreement with the University of North Carolina- Chapel Hill. Under Dr. Mundy’s guidance, Dr. Druwe developed high throughput (HTP) screening assays to screen potential developmental neurotoxicants. She earned the Cellular Dynamics Innovative Research grant award in 2013 for her work using Induced Pluripotent Stem cells to screen chemicals for hazard prioritization. She joined the US EPA National Center for Environmental Assessment (NCEA) as an ORISE postdoctoral fellow in the Fall of 2014. As a postdoctoral trainee Dr. Druwe worked on the Arsenic IRIS assessment and developed Adverse Outcome Pathway’s (AOPs) for various Adverse Outcomes related to arsenic exposure. She has also worked on developing and incorporating Bayesian methods to integrate high throughput data for chemical risk prioritization. Dr. Druwe recently accepted a position as a staff Toxicologist at the US EPA to support Integrated Risk Information System (IRIS) where she will be using her expertise in Toxicology, neurobiology, molecular mechanism biology and bioinformatics to support US EPAs IRIS human health assessments.
|
|
|
|